TLR4 and obesity disorder: TLR4 is a well-known activator of innate immune responses against pathogens and has recently been shown to mediate obesity-induced cardiac inflammation, glucose metabolic derangement and injury (Jackson et al., 2015; Chen et al., 2020; Liu et al., 2020).